Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck 2019 Restructuring Program (legacy) by Year
2019 Restructuring Program (legacy) — Ending Accrual Reserve Balance ($M) ($M)
Merck 2019 Restructuring Program (legacy): $597M in FY2023, up 16.4% from a year earlier. No newer figure appears in the documents we track.
Where the FY2023 figure comes from
Source: Form 10-K (filed 2024-02-26) ↗
Reported in Form 10-Q / 10-K Restructuring Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 2019 Restructuring Program (legacy) — Ending Accrual Reserve Balance ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 597 | +16.4% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 513 | -19.5% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 637 | – | Form 10-K (filed 2024-02-26) ↗ |
Cite this data
StockData. (2026). Merck 2019 Restructuring Program (legacy) ($M), annual FY2021–FY2023 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/restr-program2019-res-tot
See every metric in the Merck KPI table. Data updated Oct 26, 2026.